Nordea Investment Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-884,642
| Closed | -$1.01M | – | 886 |
|
|
2025
Q1 | $1.01M | Buy |
884,642
+367,457
| +71% | +$421K | ﹤0.01% | 809 |
|
|
2024
Q4 | $915K | Buy |
517,185
+91,559
| +22% | +$162K | ﹤0.01% | 818 |
|
|
2024
Q3 | $747K | Sell |
425,626
-6,711
| -2% | -$11.8K | ﹤0.01% | 848 |
|
|
2024
Q2 | $594K | Buy |
432,337
+218,182
| +102% | +$300K | ﹤0.01% | 866 |
|
|
2024
Q1 | $815K | Buy |
214,155
+71,398
| +50% | +$272K | ﹤0.01% | 851 |
|
|
2023
Q4 | $1.41M | Sell |
142,757
-6,374
| -4% | -$63K | ﹤0.01% | 762 |
|
|
2023
Q3 | $1.25M | Buy |
149,131
+40,667
| +37% | +$342K | ﹤0.01% | 771 |
|
|
2023
Q2 | $1.5M | Sell |
108,464
-26,952
| -20% | -$373K | ﹤0.01% | 739 |
|
|
2023
Q1 | $1.45M | Buy |
+135,416
| New | +$1.45M | ﹤0.01% | 719 |
|